Sign In
Buy BLCO
$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
04:30pm, Wednesday, 29'th May 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
06:59am, Tuesday, 28'th May 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Health Ca
Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript
01:38pm, Wednesday, 01'st May 2024
Bausch + Lomb Corporation (NYSE:BLCO ) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants George Gadkowski - VP, IR & Business Insights Brent Saunders - Chairman & CEO Sam El
Bausch + Lomb Announces First-Quarter 2024 Results
06:58am, Wednesday, 01'st May 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quar
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
07:00am, Monday, 29'th Apr 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
08:30am, Thursday, 25'th Apr 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in O
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
11:06am, Wednesday, 24'th Apr 2024
Bausch + Lomb (BLCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
12:00pm, Monday, 15'th Apr 2024
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter
BLCO vs. AVTR: Which Stock Is the Better Value Option?
12:41pm, Monday, 08'th Apr 2024
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value
All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy
01:01pm, Monday, 25'th Mar 2024
Bausch + Lomb (BLCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BLCO or AVTR: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 21'st Mar 2024
Investors interested in stocks from the Medical Services sector have probably already heard of Bausch + Lomb (BLCO) and Avantor, Inc. (AVTR). But which of these two stocks offers value investors a bet
BLCO or AVTR: Which Is the Better Value Stock Right Now?
11:46am, Thursday, 21'st Mar 2024
Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or Avantor, Inc. (AVTR). But which of these two stocks presents investors with the better
Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock
01:21pm, Wednesday, 20'th Mar 2024
Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript
01:07pm, Wednesday, 21'st Feb 2024
Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript
